$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Buy this Medical Sector Pioneer Stock
01:33pm, Tuesday, 22'nd Nov 2022
Gilead Sciences (GILD) is up roughly 20% since its Q3 release in October, let's take a look at what could continue propelling GILD stock.
Moderna, Applied Materials Are Candidates for a January Rebound
10:48am, Monday, 21'st Nov 2022
Stocks that are killed in a given year often come back to life the following year, especially in January.
Pfizer (PFE), BioNTech Provide New Data on BA.4/BA.5 Boosters
10:35am, Monday, 21'st Nov 2022 Zacks Investment Research
Pfizer (PFE) and BioNTech's (BNTX) Omicron BA.4/BA.5-adapted bivalent vaccines show improved immune response against newer Omicron sublineages.
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
11:30am, Sunday, 20'th Nov 2022 The Motley Fool
Innovative products and services could keep these companies growing.
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
06:30am, Sunday, 20'th Nov 2022
Innovative products and services could keep these companies growing.
These Wildly Undervalued Stocks Could Go Parabolic
11:00am, Saturday, 19'th Nov 2022 The Motley Fool
These stocks could be heading for a big recovery.
Moderna is developing vaccine booster shot to fight South Africa Covid strain
08:02am, Saturday, 19'th Nov 2022
Moderna's researchers say the current vaccine may be less effective against the South African Covid strain. They are planning to test a booster shot vaccine and develop a new vaccine to target Covid v
Final Trades: Boeing, Moderna, Melco & more
03:31am, Saturday, 19'th Nov 2022
The "Halftime Report" traders give their top picks to watch for the second half.
2 Concerning Trends That Make Moderna a Risky Buy
02:00pm, Thursday, 17'th Nov 2022 The Motley Fool
Investors should expect this to be a volatile stock for the foreseeable future.
The Zacks Analyst Blog Highlights Merrimack Pharmaceuticals, Moderna and Seagen
11:56am, Thursday, 17'th Nov 2022 Zacks Investment Research
Highlights Merrimack Pharmaceuticals, Moderna and Seagen are included in this Analyst Blog.
3 Stocks I'm Planning to Buy Very Soon
11:32am, Thursday, 17'th Nov 2022 The Motley Fool
I don't own these three stocks yet, but they all have massive potential and trade for steep discounts.
Biotech Stock Roundup: MACK Up on Study Data, MRNA Offers Vaccine Update & More
04:28pm, Wednesday, 16'th Nov 2022 Zacks Investment Research
Pipeline updates from MACK and MRNA are the key highlights from the biotech sector during the past week.
Moderna, Inc. (MRNA) 13th Annual Jefferies London Healthcare Conference 2022 - (Transcript)
12:03pm, Wednesday, 16'th Nov 2022
Moderna, Inc. (NASDAQ:MRNA ) 13th Annual Jefferies London Healthcare Conference 2022 Call November 15, 2022 10:50 AM ET Company Participants Stephen Hoge - President Conference Call Participants Micha
Moderna's (MRNA) Omicron BA.4/5 Booster Jab Study Meets Goal
09:16pm, Tuesday, 15'th Nov 2022 Zacks Investment Research
Moderna's (MRNA) Omicron-targeting bivalent COVID vaccines exhibit substantial antibody response compared with an original booster dose of Spikevax.
Moderna's (MRNA) Omicron BA.4/5 Booster Jab Study Meets Goal
05:19pm, Tuesday, 15'th Nov 2022
Moderna's (MRNA) Omicron-targeting bivalent COVID vaccines exhibit substantial antibody response compared with an original booster dose of Spikevax.
Sign In
Buy MRNA